00:01    |    
Initial credits
00:20    |    
Introduction
00:30    |    
How does amyotrophic lateral sclerosis affect people?
01:21    |    
What are the known causes of this disease?
01:50    |    
What is the best way to deal with diseases that have unknown causes?
02:59    |    
What are the new therapies?
04:18    |    
Are humans being exposed to this therapy?
04:59    |    
How do patients qualify for the therapy?
06:03    |    
When will this drug be available to the public?
08:33    |    
Final words
08:42    |    
Final credits



Share

Video:

Embed:

Amyotrophic Lateral Sclerosis: Causes and Therapeutic Advances

23 de marzo de 2010   | Vistas: 14 |  

About this video

Richard Smith talks about amyotrophic lateral sclerosis or ALS, a chronic neurodegenerative disease that primarily affects the neuromuscular system. The disease, which causes slow progressive paralysis, is almost always fatal. According to Smith, ten percent of ALS cases are familial, while ninety percent have no known cause. Smith explains that presently there is no cure for ALS and current therapies focus on managing symptoms. He goes on to describe the development and testing of potential therapies that are based on new genetic information available on the disease.



Créditos

Amyotrophic Lateral Sclerosis: Causes and Therapeutic Advances
Richard Smith

Business School Building, EN-605
Universidad Francisco Marroquín
Guatemala, March 23, 2010

New Media - UFM production.  Guatemala, April 2010
Camera: Mario Estrada, Jorge Samayoa; digital editing: Sergio Miranda; index and synopsis: Ximena García; content revisers: Daphne Ortiz, Jennifer Keller; publication: Carlos Petz/Daphne Ortiz




Richard A. Smith is the medical director of the Center for Neurologic Study (CNS), principal researcher at Coordinated Clinical Research,…

IDEAS DE LA LIBERTAD

Nuestra misión es la enseñanza y difusión de los principios éticos, jurídicos y económicos de una sociedad de personas libres y responsables.

Universidad Francisco Marroquín